Didier Hoch

Didier Hoch

Fortuna: 107 157 $ al 31/05/2026

70 años
Health Technology
Commercial Services
Consumer Services

Perfil

Didier Hoch is the founder of Big Booster'S (2014).
Current jobs include Co-Chairman at Underground Charity Foundation (2018), Chairman at PHAXIAM Therapeutics SA (2023), Director at Fondation Universite Grenoble Alpes, Director at Goliver Therapeutics, and Independent Member-Supervisory Board at Myasterix.
Former jobs include Chairman & Chief Executive Officer at Pherecydes Pharma SA (2022), Chairman at MSD Vaccines Ltd. (2010), Chairman at Sanofi Pasteur SA (2000-2010), Non-Executive Chairman at Pevion Biotech AG (2011-2013), Chairman at BioVision (2013-2018), Chairman at Fondation pour l’Université de Lyon (2014-2018), Chairman at OSE Immunotherapeutics SA (2024-2025), Director at DBV Technologies SA (2012-2016), Independent Director at ERYTech Pharma SA, Independent Director at Effimune SA, Independent Director at Germitec SA (2014-2019), Vice President at Rhone Poulenc Rorer (2000-2009), President at European Vaccine Manufacturers (2009-2010), Member-Supervisory Board at Genticel SA (2014-2017), President-Life Science Health Committee at Mouvement des Entreprises de France, and Vice President-Africa & Middle East Region at Aventis Pharma International SAS. Education includes an undergraduate degree from ESCP Europe Campus Paris and a doctorate from the University of Lyon (1984).

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
12/09/2025 20.965 ( 0,09 % ) 107 157 $ 31/05/2026

Cargos activos de Didier Hoch

EmpresasCargoInicio
PHAXIAM THERAPEUTICS S.A. Presidente 23/06/2023
Goliver Therapeutics
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Underground Charity Foundation
Presidente 01/01/2018
Myasterix
Director/Miembro de la Junta -

Antiguos cargos conocidos de Didier Hoch.

EmpresasCargoFin
OSE IMMUNOTHERAPEUTICS Presidente 30/09/2025
Director/Miembro de la Junta 01/01/2019
Fondation pour l’Université de Lyon
Presidente 02/01/2018
BioVision
Presidente 01/01/2018
░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Didier Hoch.

Formación de Didier Hoch.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

59

Relaciones de 1er grado

24

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas24

Process Industries

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

European Vaccine Manufacturers

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

BioVision

Myasterix

Fondation pour l’Université de Lyon

Health Technology

Aventis Pharma International SAS

Underground Charity Foundation

Commercial Services

Goliver Therapeutics

Commercial Services

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN